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A NUMBER of continuous tissue culture lines have been established from
patients (mostly children) with Burkitt's tumour (Epstein and Barr, 1964;
Pulvertaft, 1964; Stewart et al., 1965). Most of these strains have been derived
from African patients, although this tumour is found, ifrarely, in other parts ofthe
world (Wright, 1966). It was therefore ofconsiderable interest when this singular
tumour was described in a 15 year old girl who had lived in England all her life
(Seed, 1966) and when Epstein and his colleagues established a continuous cell
line from biopsy material taken from this tumour (Epstein, Barr and Achong,
1966). The following report describes chromosomal and other findings in these
cells after 15 months in continuous culture.
METHODS
The EB4 strain of Burkitt tumour cells was received from Dr. Epstein and
subsequently cultured in Eagle's Minimal Essential Medium with 1 Y% non-essential
amino-acids, 2 mm glutamine and 20 % foetal calfserum with added penicillin and
streptomycin. For chromosomal study, cells were arrested at metaphase by
addition of colcemid about 22 hours after the tissue culture medium had been
changed. The slides were dried by air and the chromosomes were stained with
2 %° lacto-acetic orcein.
For the cell growth study, cell counts were carried out at 2-hourly intervals,
22 hours after changing the medium. Subsidiary experiments showed that the
error implicit in the counting technique was less than ± 5 %. Tritiated thymidine
(1.9 Ci/mM) was added in an appropriate amount 22 hours after changing the
medium and samples taken at two hourly intervals. Autoradiographic treatment
ofslides followed the method described by Yunis (1966).
RESULTS
Chromosomes
Chromosomal analysis was carried out on 4 different occasions during a 2-
month period after the cells had been in culture for about 14 months. Table I
shows the chromosome counts obtained on each occasion.
Seventy-two per cent of the cells examined had a chromosome count of 46
(i.e. the modal number); this included a marker chromosome involving a member
of Group D (Fig. 1). Whilst there are several explanations for the origin of this
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TABLE I.-The Chromosomes in the EB4 Line ofBurkitt Tumour Cells
Sample tetra poly-
number < 44 45 46 47 48 ploid ploid Total
1. . 8. 8. 85 . 0 .0 . 11 . .110
2. 4 .15. 82 . 0 .1. 10. . 110
3. . 1.11. 72. 4. 0. 2.-. 90
4. . 6 5 . 60 . 3 . 0 . 11 . 4 . 87
Total
cells . 19 . 39 . 299 . 7 . 1 . 34 . 4 . 397
% . 5413 . 10-32 . 72-19 . 189 . 0-27 912 . 1*08 . 100
marker chromosome, the most likely one is a duplication of the long arm of a
Group D chromosome.
A high degree of hypodiploidy (15 %) was observed but no special significance
was attached to this as many of the cells showed inconsistent chromosome loss,
although the marker chromosome remained constantly present.
The percentage ofhyperdiploidy was low (2 %) and all cells showed inconstant
chromosomal gain. The marker chromosome was, however, again constantly
present (Fig. 2).
Tetraploid cells were commonly found (9-10 %) with many of the cells under-
going endoreduplication (Fig. 3 and 4).
Growth characteristiCs
Both the cell counts and tritiated thymidine experiments (Fig. 5) were carried
out in the initial log phase period after changing the medium. Both experiments
show that there is then a drop in cell numbers and numbers of cells synthesising
DNA. After a further 8 hour interval, they recovered and then gradually declined
again unitil the medium was renewed.
DISCUSSION
We have no information on the chromosomal morphology of these cells when
they were first cultivated and, in consequence, it is impossible to assess any
changes which may have occurred during the 15 months that these cells have been
in continuous culture.
One report (Cooper, Hughes and Topping, 1966) showed in 2 (namely, EBI,
EB2) of3 lines ofBurkitt tumour cells (EB1, EB2, EB3) that a cytogenetic change.
occurred (from normality to a heteroploid complement of 86-88 chromosomes)
during a period of 1 year in culture.
Miles and O'Neill (1967) working on 8 cell lines ofthe Burkitt's tumour found
no constant chromosomal abnormality among the different lines. Toshima et al.,
EXPLANATION OF PLATES
FIG. 1.-Karyotype of cell containing 46 chromosomes with one of the Group D being Marker
Chromosome M.
FIG. 2.-Karyotype of a cell with 47 chromosomes including the Group D Marker, plus a
centric fragment (arrowed).
FIG. 3.-Karotype of a tetraploid cell showing 2 marker chromosomes.
FIG. 4.-Karyotype of an endoreduplicated cell with the marker chromosome also duplicated.
Chromosome re-arrangement is also shown (arrowed).BRITISH JOURNAL OF CANCER.
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(1967) also reported their cytogenetic findings on the SLI, Ogun, Jiyoye, and
B-35-M Burkitt's cell lines, and did not find a constant marker chromosome
among these 4 lines of cells. On the other hand, Kohn et al., (1967) demonstrated
a marker chromosome in the C group from 4 out of 5 Burkitt tumour cell lines;
the proportion of cells showing this chromosome increased with the period of time
that the line had been in culture. Such changes are compatible with the conjoint
action of such a virus as has been demonstrated in cells of this type by Epstein
and other workers (Epstein, Achong and Barr, 1964; Stewart et al., 1965; O'Conor
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FIG. 5. Graphs relating to cell growth and DNA uptake studies in EB4 cells.
and Rabson, 1965; Hummeler, Henle and Henle, 1966) and the diminution on
sub-culture of the normal mechanisms of immunological surveillance. They are
not seen after continued sub-culture of apparently virus-free diploid cells of
foetal origin (e.g. W138 and WI26) (Hayflick, 1965; Boue, 1967, personal com-
munication.)
Our findings of a marker chromosome in a different group (Group D) in the
EB4 line of cells does not invalidate this hypothesis and, indeed, supports it
in so far as it would be very surprising ifone or any virus consistently affected any
particular chromosome. Further serial investigations of all these cell lines will
eventually establish whether the chromosome abnormalities are caused by onco-
genic viral activity or different laboratory procedures.
The growth characteristics ofthese cells were investigated by the incorporation
of tritiated thymidine (as an index of new cellular DNA formation) and by the use678 N. P. BISHUN AND R. N. P. SUTTON
of serial counts, using vitally stained cells, to relate this to the microscopically
observable evidences of cell growth. A change in activity was demonstrable as
the cells changed from the lag to the log phase of growth. Similar observations
were made by Cooper and his colleagues (1966) in the case of the EB3 line of
Burkitt tumour cells.
SUMMARY
Cytogenetic studies on the EB4 Burkitt tumour cell line revealed a constant
marker chromosome involving Group D. The growth pattern of the cell line
was also studied using tritiated thymidine labelling and vital staining techniques.
We wish to thank Mr. P. M. Bracken, F.I.M.L.T., and Miss D. M. Chambers,
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